← Back to Search

Microneedling

Straberi Epistamp Needling Treatment for Ehlers-Danlos Syndrome (ESAA Trial)

N/A

Waitlist Available

Led By Maurice Wright, MD

Research Sponsored by Universal Skincare Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

ESAA Trial Summary

This trialwill study how a device improves skin's collagen and elastin for smoother skin and fewer wrinkles. #MedicalResearch

Eligible Conditions

Wrinkles
Ehlers-Danlos Syndrome
Collagen Degeneration

ESAA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The Global Aesthetic Improvement Scale (GAIS)

Secondary outcome measures

Overall Skin improvement assessed by Derma Scan

Photographs

To evaluate the impact on the quality of life (DLQI)

+1 more

ESAA Trial Design

2Treatment groups

Experimental Treatment

Group I: Straberi Epistamp Needling TreatmentExperimental Treatment1 Intervention

Non-Randomized treatment for patients who seek improvement for elastin, fine lines, deep wrinkles, and collagen production using Straberi Epistamp needling treatment

Group II: No TreatmentExperimental Treatment1 Intervention

Non-Randomized patients who seek improvement for elastin, fine lines, deep wrinkles, and collagen production.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Straberi Epistamp Microneedling Treatment

2022

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Universal Skincare InstituteLead Sponsor

2 Previous Clinical Trials

55 Total Patients Enrolled

Lavish BeautyUNKNOWN

2 Previous Clinical Trials

55 Total Patients Enrolled

Maurice Wright, MDPrincipal InvestigatorColumbia University/ Harlem Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for participants of this clinical trial?

"According to information posted on clinicaltrials.gov, this investigation is presently recruiting participants who meet criteria for the study. It was initially launched on November 21st 2022 and was amended most recently in October 27th 2022."

Answered by AI

What is the aggregate number of participants this clinical trial has yielded?

"Affirmative. Evidenced by the clinicaltrials.gov listing, this investigation is currently in search of volunteers. It was posted on November 21st 2022 and updated as recently as October 27th 2022, with a recruitment goal of 30 individuals at one site."

Answered by AI

Does this research protocol allow for individuals aged 45 or older to participate?

"This trial welcomes any individuals aged between 29 and 65 years old."

Answered by AI

What criteria must be met in order to participate in this clinical trial?

"Eligibility for this medical trial requires that participants have dermal tissue and are between 29 and 65 years old. There is an ongoing search to recruit roughly 30 qualified individuals."

Answered by AI

What goals is this experiment attempting to reach?

"Over the course of 6 months, this clinical trial aims to assess patient outcomes with The Global Aesthetic Improvement Scale (GAIS). Secondary objectives include evaluation via Wrinkle Severity Rating Scale (WSRS), Dermatology Life Quality Index questionnaire (DLQI) and photographic evidence captured by a digital imaging device. Scores for WSRS range from 0-4 while DLQI is tabulated through 10 questions scoring between 0-3 each; photographs are quartile graded based on improvement percentage."

Answered by AI

Recent research and studies

Clinical and Experimental DermatologyJournal

Dermatology Life Quality Index (dlqi)-a Simple Practical Measure for Routine Clinical Use

FINLAY, A.Y., and G.K. KHAN. 1994. “Dermatology Life Quality Index (dlqi)-a Simple Practical Measure for Routine Clinical Use”. Clinical and Experimental Dermatology. Wiley. doi:10.1111/j.1365-2230.1994.tb01167.x.

clinicaltrials.govStudy

Straberi Epistamp Needling Treatment For Skin Rejuvenation

2022. "Straberi Epistamp Needling Treatment For Skin Rejuvenation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04742803.